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Abstract
Overwhelming activation of IL-17, a gene involved in inflammation, leads to exaggerated Th17 responses associated with
numerous autoimmune conditions, such as experimental autoimmune encephalomyelitis (EAE). Here we show that TCF-1 is
a critical factor to repress IL-17 gene locus by chromatin modifications during T cell development. Deletion of TCF-1 resulted
in increased IL-17 gene expression both in thymus and peripheral T cells, which led to enhanced Th17 differentiation. As a
result, TCF-1
-/- mice were susceptible to Th17-dependent EAE induction. Rag1
-/- mice reconstituted with TCF-1
-/- T cells were
also susceptible to EAE, indicating TCF-1 is intrinsically required to repress IL-17. However, expression of wild-type TCF-1 or
dominant negative TCF-1 did not interfere with Th17 differentiation in mature T cells. Furthermore, expression of TCF-1 in
TCF-1
-/- T cells could not restore Th17 differentiation to wild-type levels, indicating that TCF-1 cannot affect IL-17 production
at the mature T cell stage. This is also supported by the normal up-regulation or activation in mature TCF-1
-/- T cells of
factors known to regulate Th17 differentiation, including RORct and Stat3. We observed hyperacetylation together with
trimethylation of Lys-4 at the IL-17 locus in TCF-1
-/- thymocytes, two epigenetic modifications indicating an open active state
of the gene. Such epigenetic modifications were preserved even when TCF-1
-/- T cells migrated out of thymus. Therefore,
TCF-1 mediates an active process to repress IL-17 gene expression via epigenetic modifications during T cell development.
This TCF-1-mediated repression of IL-17 is critical for peripheral T cells to generate balanced immune responses.
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Introduction
In response to antigen stimulation, naı ¨ve T cells have the
potential to differentiate into multiple lineages of T helpers such as
Th1, Th2, Th17 and regulatory T cells (Treg). Because the
different T helpers perform distinct, sometimes even opposite,
functions [1], balanced differentiation to different T helpers is
critical for maintaining properly immune responses. Inappropri-
ately enhanced or reduced potential for forming specific types of T
helpers leads to either autoimmunity or immunodeficiency. Many
studies have focused on how the cytokine environment regulates T
cell differentiation into different types of T helpers; however, little
is known about whether and how the developmental process
programs T cells to generate balanced immune responses once
they migrate out to periphery. Positive and negative selection
during development of T cells in the thymus ensures that mature T
cells are responsive only to foreign but not self-antigens [2].
Another function of T cell development in the thymus is to
program T cells such that they have unbiased potential to form
different lineages of T helpers, as biased potential to form a specific
type of T helper leads to unbalanced immune responses.
Identification of the Th17 lineage has changed the traditional
Th1/Th2 paradigm by adding a new lineage of T helpers [3]. In
2003, Cua et al. made the seminal observation that IL-23, but not
the Th1 cytokine IL-12, was critical for the development of
experimental autoimmune encephalomyelitis (EAE), which had
long been believed to be a Th1-dependent autoimmune disease
[4]. IL-23 was required for the expansion of IL-17-producing
pathogenic T cells, which induced EAE when adoptively
transferred to naı ¨ve mice [5]. Th17 cells produce IL-17, IL-21
and IL-22 cytokines [6], and IL-17 induces massive tissue
inflammation due to broad distribution of its receptors on both
immune and nonimmune cells [6]. In addition to EAE, Th17 has
also been identified as the pathogenic T cell in an animal model of
collagen-induced arthritis [7] and inflammatory bowel disease
(IBD) [8]. Circumstantial evidence has also accumulated suggest-
ing the pathologenic role of Th17 cells in multiple human
autoimmune disorders, including multiple sclerosis [9], rheuma-
toid arthritis [10], asthma [11], IBD [12] and psoriasis [13]. A
greater understanding of the mechanisms responsible for regulat-
ing the differentiation of Th17 will therefore facilitate the
development of treatments that target Th17-mediated autoimmu-
nity [14]. Stimulation of naı ¨ve T cells in the presence of TGFb and
IL-6 is sufficient to form IL-17-producing T cells [15], and IL-6
activates Stat3, which is essential for formation of Th17 cells [16].
In addition, IL-6 and TGFb together are required to induce
RORct, a master regulator of Th17. T cells deficient in RORct
fail to become IL-17 producing cells, even in the presence of
TGFb and IL-6 [17]. So far, almost all the factors known to
interfere with Th17 differentiation do so by direct or indirect
regulation of RORct expression [18]. Peripheral T cells in
RORct
-/- mice can form Th17 cells once RORct is provided [17],
suggesting that RORct is not required for the thymic development
of T cells with the potential to form Th17 cells. However, it is still
unclear whether the potential of Th17 formation is regulated
during T cell development in thymus.
T cell factor 1 (TCF-1) is a transcription factor that is enriched
in hematopoietic cells and plays an important role in T cell
PLoS ONE | www.plosone.org 1 September 2011 | Volume 6 | Issue 9 | e24768Figure 1. TCF-1 is required to repress the IL-17 gene during T cell development. (A) Increased expression of IL-17 mRNA in TCF-1
-/- but not
b-cat
Tg thymocytes. Levels of IL-17A and IL-17F mRNAs from WT, TCF-1
-/- or b-cat
Tg thymocytes, as determined by qRT-PCR; n=4; error bars indicate
6SEM. (B-C) Increase in natural Th17 cells in TCF-1
-/- mice. T cells from thymus (B) or peripheral lymphocytes (C) of WT or TCF-1
-/- mice were
stimulated with PMA and ionomycin for 4 h immediately after isolation, and the percentage of natural Th17 gated on CD4
+TCR-b
+ cells was detected
by intracellular staining for IL-17. Shown contour plots are representative of three independent experiments. (D) Increased IL-17 but not IFNc
producing T cells in lamina propria lymphocytes. Lamina propria lymphocytes from WT and TCF-1
-/- mice were either not treated (top panels) or
stimulated with PMA/Ionomycin (bottom panels). IL-17 and IFNc producing cells were detected by flow cytometry.
doi:10.1371/journal.pone.0024768.g001
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differentiation in the periphery [25]. TCF-1 plays an important
role in the CD4
-CD8
- double negative to CD4
+CD8
+ double
positive transition stage [19] and in regulating double positive
thymocyte survival [21]. In addition to its function in T cell
development, TCF-1 also regulates T cell differentiation. Although
T cell activation seems normal in the absence of TCF-1 [19], TCF-
1
-/- T cells exhibit defects in differentiation to Th2 [25]. TCF-1
promotes Th2 through direct transcriptional activation of GATA-
3, a master gene for Th2 differentiation, but likely does not act by
affecting Th2 differentiation potential during thymic development,
as such an effect can be observed by forced expression of dominant
negative TCF-1 in wild-type (WT) mature T cells [25]. Further
support for this idea comes from the observation that b-catenin,
the TCF-1 co-activator, enhanced TCF-1-mediated stimulation of
Th2 differentiation when expressed in WT mature T cells.
Therefore, the question still remains whether TCF-1-mediated
function in thymus eventually affects T cell function once the cells
migrate into the periphery.
In this study, we demonstrate that TCF-1 is required to
epigenetically maintain the IL-17 gene locus in a repressive state.
Deletion of TCF-1 opens the IL-17 locus during T cell
development, resulting in a high potential for differentiation of
T cells into Th17 cells. Enhanced Th17 formation by deletion of
TCF-1 was also demonstrated by increased susceptibility of TCF-
1
-/- mice to EAE induction. Furthermore, susceptibility to EAE
was also observed when TCF-1
-/- T cells were adoptively
transferred into Rag1
-/- mice, indicating that TCF-1 is intrinsically
required to repress IL-17 production. However, forced expression
of WT TCF-1 or dominant negative TCF in mature T cells could
not interfere with IL-17 expression, suggesting that TCF-1
modulates the IL-17 locus only during the development stage.
Once T cells are mature, TCF-1 can no longer affect IL-17
expression. This idea is further enhanced by our finding that
forced expression of TCF-1 in TCF-1
-/- mature T cells did not
change the phenotype of enhanced IL-17 production. Therefore,
our results demonstrate that TCF-1 regulates the developmental
program to repress the IL-17 locus, resulting in modulation of the
potential for Th17 formation of mature T cells.
Materials and Methods
Ethics Statement
All mice were housed under specific pathogen-free conditions
and experiments were performed in accordance with a protocol
approved by the Institutional Animal Care and Use Committee at
the Beckman Research Institute of City of Hope (IACUC#07023).
Mice
TCF-1
-/- mice [26] and b-catenin transgenic (b-cat
Tg) mice [23]
were described previously. Rag1
2/2 mice were initially obtained
from Dr. Defu Zeng (Beckman Research Institute of City of Hope).
All mice were housed under specific pathogen-free conditions and
experiments were performed in accordance with a protocol
approved by the Institutional Animal Care and Use Committee at
theBeckmanResearch Institute ofCityofHope.The approvalIDis
IACUC#07023.
T-cell isolation and differentiation
Naı ¨ve (CD4
+CD25
2CD44
lowCD62L
hi) T cells were isolated
from lymph nodes and spleens of mice by cell sorting using a
FACSAiraII cell sorter (BD Bioscience, San Jose, CA). In vitro
differentiation of naı ¨ve T cells into ThN or Th17 cells was done as
described [27]. In brief, 2610
5 cells were stimulated with 0.25 mg/
mL anti-CD3 (145-2C11, eBioscience, San Diego, CA) and 1 mg/
mL anti-CD28 (37.51, eBioscience) in goat-anti-hamster IgG
(0.2 mg/mL, MP Biomedicals, Santa Ana, CA) pre-coated 24-well
plates. For ThN cells, no further supplements were added; for
Th17 cells, 10 mg/mL anti-IFN-c (XMG1.2, BioXcell, West
Lebanon, NH), 10 mg/mL anti-IL-4 (11B11, BioXcell), 20 ng/mL
mouse IL-6 (Peprotech, Rocky Hill, NJ) and 0.5 ng/mL human
TGF-b1 (Peprotech) were added. T cells were cultured for 3 d in
RPMI1640 (Cellgro, Mediatech, Manassas, VA, USA) containing
2 mM L-glutamine, 50 mM b-mercaptoethanol, 100 U/mL pen-
icillin, 100 mg/mL streptomycin and 10% FBS.
Intracellular cytokine measurements and flow cytometry
For cytokine analysis, cultured ThN or Th17 cells, or freshly
isolated thymocytes and peripheral lymphocytes, were stimulated
with 10 nM PMA and 1 mM ionomycin (Sigma-Aldrich, St. Louis,
MO) for 4 h in the presence of 5 mM Brefeldin A. Antibodies were
purchased from eBioscience, unless otherwise indicated. Following
Fc block with anti-CD16/32 (clone 93), cells were incubated with
anti-mouse CD4 (clone L3T4) and anti-mouse TCR-b (clone
H57-597, BD Bioscience) and fixed/permeabilized either with the
BD Cytofix/Cytoperm kit (BD Bioscience) or Foxp3 Staining
Buffer (eBioscience). Cells were intracellularly stained with the
following antibodies: anti-mouse IL-17A (clone eBioTC11-
18H10.1), anti-mouse RORct (clone AFKJS-9) and anti-mouse
Foxp3 (clone FJK-16S), and analyzed using a BDCantoII
cytometer (BD Biosciences) and FlowJo software (Treestar,
Ashland, OR).
Isolation of lamina propria lymphocytes
Method was adopted from Weigmann B (Nature protocol 2007).
In brief, after carefully removal of Peyer’s patches, fat tissue, and
feces, small intestines were cut longitudinally first, then cut into
1 cm pieces. After two rounds of incubation at 37uC for 20 min in
PBS with 5 mM EDTA and 1 mM DTT, gut tissues were washed
with cold PBS and cut into 1 mm
2 pieces. Tissues were incubated
with 0.5 mg/ml collagenase D (Sigma-Aldrich), 0.5 mg/ml DNaseI
(Sigma-Aldrich) and 3 mg/ml Dispase II (Roche) in PBS with 4%
FBS for 20 min at 37uC with agitation. After incubation, tissues
were forced to pass 40 mM filter and precipitated to pellet. Cells
were further stained with anti-CD4-FITC and anti-TCR-b-PE
(eBioscience) and sortedas CD4+TCR-b+ cells by BDFACSAria II.
Retroviral Packaging and Transduction
MSCV-IRES-EGFP based retroviral bicistronic expression
vectors encoding TCF-1, dominate negative TCF-1 (dnTCF-1),
b-catenin or constitutively active b-catenin were transfected into
phoenix cells using lipofectamine 2000 (Invitrogen). After
48 hours, viral supernatants were collected and stored at 280uC
until use. For transduction, naı ¨ve T cells were first activated with
anti-CD3 (1 ug/ml) and anti-CD28 (1 ug/ml) antibodies for
24 hours, then spin infected with viral supernatants (2500 rpm,
30uC for 2 hours) in the presence of 8 ug/ml of polybrene (Sigma-
Aldrich). After spin infection, cytokines were added in culture
media for T cell differentiation.
EAE
EAE was induced as described [27]. Briefly, mice were
immunized with 200 mL myelin oligodendrocyte glycoprotein
35–55 (MOG35–55) peptide emulsion (Hooke Laboratories,
Lawrence, MA). On days 0 and 2 after immunization, mice were
injected with 200 ng pertussis toxin (List Biological Laboratories,
Campbell, CA). The severity of EAE was monitored and evaluated
Regulation of IL-17 Gene by TCF-1
PLoS ONE | www.plosone.org 3 September 2011 | Volume 6 | Issue 9 | e24768on a scale from 0 to 5 according to Hooke Laboratories’ guideline;
in brief: 0= no disease; 1= paralyzed tail; 2= hind limb
weakness; 3= hind limb paralysis; 4= hind and fore limb
paralysis; 5= moribund and death. When a mouse was
euthanized because of severe paralysis, a score of 5 was entered
for that mouse for the rest of the experiment.
Figure 2. TCF-1
-/- T cells have a high potential to form Th17 cells. (A) Isolated naı ¨ve CD4
+ T cells from WT control or TCF-1
-/- mice were
differentiated in neutral conditions (without cytokines) or Th17 conditions (TGFb + IL-6) for three days. Intracellular IL-17A was then stained and
analyzed by flow cytometry. (B) Percentage of IL-17A producing cells as averaged (mean6SEM) from six independent experiments performed as
described in A. (C) mRNA levels of IL-17A, IL-17F and IL-23R in ThN and Th17 cells described in A were determined by quantitative RT-PCR;
mean6SEM from four independent experiments performed in triplicate.
doi:10.1371/journal.pone.0024768.g002
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CD4 T cells were isolated with purity greater than 95% from
spleens and lymph nodes of WT and TCF-1
-/- mice, by negative
selection using a CD4 selection kit and MACS Separation
Columns (Miltenyi Biotec, Auburn, CA). WT CD4 cells (1610
6
or 3610
6 per mouse) or TCF-1
-/- CD4 cells (1610
6 per mouse)
were injected intravenously into unirradiated Rag1
-/- mice. EAE
was induced 24 h after cell transfer.
Ex vivo stimulation of MOG35–55-specific T cells
Mice were immunized with 200 ml MOG35–55 emulsion without
injection of pertussis toxin. Twelve days later, cells were isolated
from lymph nodes and spleen and stimulated with 40 mg/mL
MOG35–55 in the presence of 10 ng/mL IL-23 (eBioscience) for 3
d. Viable lymphocytes were isolated by Ficoll-Paque centrifugation
and analyzed for IL-17A production by flow cytometry.
STAT3 phosphorylation
Freshly isolated naı ¨ve T cells were incubated (30 min, 37uC, 5%
CO2) with or without 20 ng/mL IL-6. Cells were fixed in 4%
paraformaldehyde, permeabilized with 90% methanol (220uC)
and washed with PBS containing 1% BSA. Following Fc block
with anti-CD16/32, cells were incubated with anti-mouse CD4
(L3T4, eBioscience) and anti-mouse STAT3 (pY705, clone 4/P-
STAT3, BD Biosciences).
Real-time PCR
Quantitative RT-PCR was performed as described [28]. Briefly,
Total RNA was extracted from T cells or thymocytes with the
RNeasy Mini Kit (Qiagen, Germantown, MD). cDNA was
synthesized from total RNA using oligo(dT) primers and the
Superscript III First-Strand kit (Invitrogen, Carlsbad, CA). Gene-
specific cDNAs were amplified using the Ssofast EvaGreen
Supermix (Bio-Rad, Hercules, CA) and a CFX thermocycler (Bio-
Rad).Cyclingconditionswere95uCfor30 sfollowedby40cyclesof
95uC for 2 s, 60uC for 5 s. EvaGreen signals were captured at the
end of each annealing and extension step (60uC). Threshold cycles
for each transcript (CT) were normalized to GAPD (DCT). Gene
expression is shown as 0.5
DCT610
6. Real-timePCRreactions were
performed in triplicate. Primer sequences are as following: IL-17A:
59-CTCCAGAAGGCCCTCAGACTAC-39,5 9-AGCTTTCCC-
TCCGCATTGACACAG-39; IL-17F: 59-GAGGATAACACTG-
TGAGAGTTGAC-39,5 9-GAGTTCATGGTGCTGTCTTCC-
39; IL-23R: 59-TCAGTGCTACAATCTTCAGAGG-39,5 9-
GCCAAGAAGACCATTCCCGA-39; RORct: 59-CCGCTGA-
GAGGGCTTCAC-39,5 9-TGCAGGAGTAGGCCACATTAC-
A-39; RORa:5 9-CAATGCCACCTACTCCTGTCC-39,5 9-GC-
CAGGCATTTCTGCAGC-39;A h r :5 9-AGCAGCTGTGTCA-
GATGGTG-39,59-CTGAGCAGTCCCCTGTAAGC-39;Runx1:
59-TACCTGGGATCCATCACCTC-39,5 9-GACGGCAGAGT-
AGGGAACTG-39; Est-1: 59-CGGGTCCCCTCCTATGACAG-
39,5 9-GAATGACAGGCTTGTCCTTGTT-39; Socs3: 59-AGC-
TCCAAAAGCGAGTACCA-39,5 9-TGACGCTCAACGTGAA-
GAAG-39; IRF4: 59-GCAATGGGAAACTCCGACAGT-39,5 9-
CAGCGTCCTCCTCACGATTGT-39; Batf: 59-CCAGAAGAG-
CCGACAGAGAC-39,5 9-GAGCTGCGTTCTGTTTCTCC-39.
Quantitative RT-PCR-based Chromatin
Immunoprecipitation (ChIP) Assay
Quantitative RT-PCR-based ChIP assay was performed with
the ChampionChIP kit (SABiosciences, Qiagen). Approximately
1610
7 cells were used per ChIP. DNA recovered from an aliquot
of sheared chromatin was used as the input sample. The remaining
chromatin was precleared with protein A-agarose beads and then
incubated (overnight, 4uC) with anti-acetyl-histone H3 (Cat. # 06-
599, Upstate, Millipore, Temecula, CA) or anti-trimethyl-histone
H3-Lys4 antibodies (Cat. # 07-473, Upstate, Millipore). Input
DNA and DNA recovered after immunoprecipitation were
analyzed by RT-PCR as described above, with primer pairs for
IL-17A promoter: 59-GCAGCAGCTTCAGATATGTCC-39,5 9-
TGAGGTCAGCACAGAACCAC-39; for IL-17 conserved non-
coding sequence 5 (CNS-5): 59-AGGCCCACAATGTAGGT-
CAG-39,5 9-CAGGCTGGGAAGTCTCTCTG-39 [29]; and b-
actin promoter: 59-CAGCCAACTTTACGCCTAGC-39,5 9-
TTTGGACAAAGACCCAGAGG-39. Results for the IL-17 locus
were first normalized to the b-actin promoter (DCT), and further
normalized to the level of the IL-17 locus in input fraction. Data
are presented as 0.5
(DCT-DCTinput)610
6.
Statistical analysis
Statistical analysis was performed using the unpaired, two-tailed
Student’s t-test.
Results
Deletion of TCF-1 leads to up-regulated IL-17 gene
expression
Previously, we and others demonstrated that the b-catenin/
TCF-1 pathway regulates thymocyte survival [21,23]. To study
the mechanisms responsible for TCF-1-regulated thymocyte
function, we performed microarray analysis of thymocytes
obtained from WT, TCF-1
-/- and transgenic mice that expressed
a stabilized b-catenin (b-cat
Tg). Thus, we could compare the gene
expression profiles among cells in which the TCF-1 pathway was
inhibited by deletion of TCF-1 and cells in which the TCF-1
pathway was activated by b-catenin. Two IL-17 genes, IL-17A
and IL-17F were up-regulated in the absence of TCF-1 (data not
shown), which was confirmed by quantitative real time-PCR
(qRT-PCR) analysis (Fig. 1A). However, expression of neither
gene was obviously changed in b-cat
Tg mice compared to WT
mice. Because IL-17A and IL-17F are critical cytokines produced
by Th17 cells and have been linked to numerous autoimmune
diseases [3,14], we further investigated the role of TCF-1 in Th17
differentiation. Marks et al. described a population of cells that
naturally produced IL-17 without differentiation, called natural
Th17 cells (nTh17), which are present in both thymus and
periphery [30]. We therefore analyzed this population of cells
(Fig. 1B-1C). Because nTh17 cells are not induced, they are a
relatively small population of cells; however, consistent with qRT-
Figure 3. TCF-1
-/- mice are susceptible to EAE. (A) EAE was induced by direct immunization of WT control and TCF-1
-/- mice with MOG35–55, and
the EAE score was determined as described in Materials and Methods; n=3 for each group; error bars indicate 6SD. (B) Reduced number of T cells in
TCF-1
-/- mice. Numbers of peripheral CD4 cells in WT control or TCF-1
-/- mice; n=4; error bars indicate 6SEM. (C) Increased Th17 cells in TCF-1
-/- mice.
Peripheral lymphocytes were restimulated with MOG35–55 and IL-23 after isolation from MOG35–55-immunized WT control and TCF-1
-/- mice. IL-17A
was measured by intracellular staining. Shown contour plots are representative of three independent experiments. (D) Rag1
-/- mice adoptively
transferred with TCF-1
-/- T cells are susceptive to EAE induction. 1610
6 or 3610
6 WT CD4 cells, or 1610
6 TCF-1
-/- CD4 cells were transferred into Rag1
-/-
mice. One day later, mice were immunized with MOG35–55 to induce EAE; n=6 for each group; error bars indicate 6SEM.
doi:10.1371/journal.pone.0024768.g003
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in TCF-1
-/- thymus (Fig. 1B). Similarly, significantly more nTh17
cells were also detected in TCF-1
-/- spleen compared to that of
WT mice (Fig. 1C). In addition, we examined lamina propria
lymphocytes for IL-17 and IFNc producing T cells (Fig. 1D). Prior
to stimulation, TCF-1
-/- mice already had more Th17 cells (2.27%)
than the WT mice (0.197) (left two panels). After PMA/Ionomycin
stimulation which amplified cytokine signals (second two panels),
41.5% of all the TCF-1
-/- T cells were IL-17 positive, whereas only
10.9% of WT T cells were producing IL-17. In contrast, there
were no obvious differences between WT and TCF-1
-/- T cells in
IFNc producing cells either prior (third two panels) or after
stimulation (right two panels). These results suggest that TCF-1 is
required to suppress IL-17 expression.
TCF-1
-/- T cells have high potential to form Th17 cells
To study the role of TCF-1 in Th17 differentiation, the abilities
of WT and TCF-1
-/- T cells to differentiate into Th17 cells were
compared. T cells were stimulated in the presence or absence of
TGFb and IL-6, critical cytokines required for Th17 formation
(Fig. 2A-2B). Remarkably, even in the absence of TGFb and IL-6
(Th neutral condition, ThN), a significant percentage of TCF-1
-/-
T cells became Th17 cells compared to the WT T cells (Fig. 2A,
top panel, and 2B). In the presence of TGFb and IL-6, TCF-1
-/- T
cells produced about 100% more Th17 cells than did WT T cells
(Fig. 2A, bottom panel, and 2B). qRT-PCR analysis confirmed an
increase in IL-17A and IL-17F mRNAs under both the ThN and
Th17 differentiation conditions in TCF-1
-/- cells (Fig. 2C). In
addition, we examined IL-23 receptor (IL-23R) expression, which
is up-regulated in Th17 cells [31]. The increased number of Th17
cells in the absence of TCF-1 was consistently associated with
increased expression of IL-23R. Taken together, our results
demonstrate the potential for Th17 formation is greatly enhanced
in the absence of TCF-1.
TCF-1
-/- mice are susceptible to EAE
To determine whether TCF-1 regulates Th17 function in vivo,
we used an EAE mouse model, Th17-dependent autoimmunity
[5]. EAE was induced in both WT and TCF-1
-/- mice by
immunization with the MOG35–55 peptide. WT mice developed
initial symptoms of EAE (limp tail) about 16 day after
immunization, whereas TCF-1
-/- mice developed EAE symptoms
much earlier at day 12 (Fig. 3A). WT C57BL/6 mice developed
mild EAE, with a clinical score of approximately 3. In contrast,
TCF-1
-/- mice developed more severe EAE, with clinical score up
to 5. This result is even more dramatic considering that TCF-1
-/-
mice had significantly fewer peripheral T cells as compared to WT
mice (Fig. 3B). In addition, we consistently detected a significantly
higher percentage of IL-17A-producing CD4 T cells in TCF-1
-/-
mice than in WT mice (Fig. 3C), suggesting the enhanced Th17
response contributed to the more severe EAE observed in TCF-1
-/-
mice. Because all tissues of the TCF-1
-/- mice had the gene
knockout, we performed adoptive transfer experiments to
specifically determine the function of TCF-1 in T cells during
the development of EAE (Fig. 3D). EAE was induced in Rag1
-/-
mice that were adoptively transferred with 1610
6 or 3610
6 WT
CD4 T cells or 1610
6 TCF-1
-/- CD4 T cells. Adoptive transfer of
1610
6 WT T cells was not sufficient to induce EAE, but transfer of
3610
6 WT T cells was able to induce EAE. In contrast, transfer of
1610
6 TCF-1
-/- T cells induced EAE more severely than that of
3610
6 WT T cells. These results demonstrated that deletion of
TCF-1 led to increased susceptibility to EAE, likely due to
enhanced Th17 responses. Thus, TCF-1 is required in vivo to
repress Th17-dependent immune responses.
Expression of factors known to regulate Th17
differentiation are not affected by lack of TCF-1
To determine the molecular mechanisms responsible for TCF-
1-regulated Th17 differentiation, we assessed factors known to
regulate Th17 differentiation. qRT-PCR analysis of RORct, a
master regulator for Th17 [17], did not detect an obvious
difference in RORct expression between WT and TCF-1
-/- T
cells, either under ThN or Th17 differentiation conditions
(Fig. 4A). Flow cytometric analysis of intracellularly stained
RORct confirmed this result (Fig. 4B). Because Stat3 is another
important factor involved in regulating Th17 differentiation, we
used an anti-phosphorylated Stat3 antibody to examine activation
of Stat3. No difference in expression of phosphorylated Stat3 was
detected between WT and TCF-1
-/- T cells (Fig. 4C), suggesting
normal activation of Stat3 in the absence of TCF-1. qRT-PCR
also revealed no difference in expression of RORa [18], Ahr [32],
Runx1 [33], Ets-1 [29,34,35], Socs3 [36], IRF4 [37], or Batf [38],
factors that have been reported to positively or negatively regulate
Th17 differentiation (Fig. 4D). Lastly, TGFb-induced Foxp3 has
been shown to inhibit RORct, a mechanism believed to control
Treg-Th17 balance. We therefore examined TGFb-induced Treg,
and lack of TCF-1 did not affect Treg differentiation (Fig. 4E).
Thus, TCF-1 seems to regulate Th17 differentiation without
affecting the above factors known to influence Th17 formation.
TCF-1 fails to affect Th17 differentiation in mature T cells
We next investigated whether TCF-1 can rescue Th17
differentiation of TCF-1
-/- T cells. A murine stem cell virus
(MSCV)-based retrovirus system was used to express TCF-1 and
b-catenin. As a control, a dominant negative TCF (dnTCF) that
can interfere with WT TCF-1 activity was also used. We first used
a TCF reporter (TOPflash) system to confirm that the TCF-1,
dnTCF and b-catenin plasmids functioned normally (Fig. 5A). b-
catenin stimulated the TCF-1 reporter, and stabilized active b-
catenin stimulated TCF-1 to a higher level. In the presence of
dnTCF, active b-catenin failed to stimulate the TCF-1 reporter
due to the expected inhibition of endogenous TCF-1. The TCF-1
reporter was most stimulated in the presence of WT TCF-1 and
active b-catenin. These results demonstrated that the retrovirus
vector-expressed TCF-1 and dnTCF functioned as expected.
Retroviruses that expressed TCF-1 or dnTCF were then used to
transduce WT or TCF-1
-/- T cells grown under Th17 differen-
Figure 4. TCF-1
-/- cells do not have significant changes in expression of factors known to regulate Th17. (A) qRT-PCR analysis of mRNA
levels of RORct in ThN and Th17 conditions; mean6SEM from four independent experiments performed in triplicate. (B) TCF-1
-/- cells normally up-
regulates RORct. Expression of RORcti nW To rTCF-1
-/- Th17 cells as determined by intracellular staining. RORct
-/- T cells cultured under Th17 condition
were used as negative controls for RORct staining (shaded area). (C) TCF-1
-/- cells normally activate Stat3. Naı ¨ve WT or TCF-1
-/- CD4 cells were
incubated with or without IL-6 for 30 min, fixed and stained with anti-STAT3 (pY705) antibody and pSTAT3 levels were determined by flow
cytometry; n=3. (D) TCF-1
-/- cells normally up-regulates factors known to regulate Th17 differentiation. qRT-PCR analysis of mRNA levels of RORa, Ahr,
Runx1, Est-1, Socs3, IRF4 and Batf in ThN and Th17 cells; mean6SEM from four independent experiments performed in triplicate. (E) Normal
differentiation of TCF-1
-/- cells to iTreg. Naı ¨ve WT or TCF-1
-/- CD4 cells were cultured with anti-CD3/CD28 and 5 ng/ml TGF-b1 to induce Foxp3
expression. Foxp3 expression was determined by flow cytometry after three days of culture; n=3.
doi:10.1371/journal.pone.0024768.g004
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for GFP expression, cells were divided into GFP-negative (no virus
infection) and GFP-positive (virus infected, and therefore
expressed protein of interest) populations. First, empty virus
(MSCV) was used for transduction (Fig. 5B, top panel). Consistent
with previous results (Fig. 2A), significantly more Th17 cells were
detected in both the GFP
- and GFP
+ populations (percentage of
Th17 cells among GFP
+ cells is indicated) in TCF-1
-/- T cells
compared to WT cells (Fig. 5B), suggesting that virus transduction
did not affect Th17 differentiation potential. TCF-1 did not affect
Th17 formation in WT T cells, which was likely not a result of
overexpression of TCF-1, as expression of TCF-1 in TCF-1
-/- T
cells also failed to affect Th17 formation (Fig. 5B, middle panel).
This result also indicated that expression of TCF-1 failed to rescue
the Th17 differentiation defects observed in TCF-1
-/- T cells.
Similarly, dnTCF, which should interfere with endogenous TCF-
1, also failed to affect Th17 differentiation in either WT or TCF-
1
-/- T cells (Fig. 2B, bottom panel). The reproducibility of above
experiments described in figure 2B was indicated by figure 2C, an
average from several independent studies. In addition, we tested
whether b-catenin, an activator of TCF-1, affected Th17
differentiation. T cells obtained from WT or transgenic mice that
expressed stabilized b-catenin (b-cat
Tg) [23] were differentiated in
ThN or Th17 conditions. No differences were observed in Th17
formation between WT and b-cat
Tg T cells (Fig. 5D–5E). This
result was confirmed using retrovirus to express b-catenin (data
not shown). As a control, we determined whether retrovirally
expressed TCF-1 can rescue TCF-1
-/- thymocyte development
(Fig. 5F). CD4-CD8- double negative thymocytes were sorted and
allowed to differentiate on stroma cells OP9-DL1 [39,40,41]. WT
T cells can differentiate into CD4+CD8+ double positive T cells,
whereas TCF-1
-/- failed to do so (data not shown) due to apoptosis
of TCF-1
-/- CD4+CD8+ cells [21,22]. Retrovirus expression either
TCF-1 or anti-apoptotic Bcl-xL rescued development of
CD4+CD8+ cells (Fig. 5F, left two panels, GFP+ cells). Whereas,
GFP- cells, which were not transduced and thus did not express
TCF-1 or Bcl-xL failed to develop into CD4+CD8+ cells. TCF-1,
that rescued defective TCF-1
-/- thymocyte development, failed to
correct abnormal Th17 differentiation in TCF-1
-/- mature T cells.
Taken together, we conclude that TCF-1 is unlikely to affect Th17
differentiation potential at the mature T cell stage.
IL-17 gene locus is in an ‘‘open’’ state in the absence of
TCF-1
Since TCF-1 does not regulate IL-17 expression in mature T
cells (Fig. 5), and IL-17 starts to up-regulate in TCF-1
-/-
thymocytes (Fig.1), it suggests a possibility that TCF-1 mediates
the repression of IL-17 gene locus in thymus instead of in
periphery. We thus examined histone H3 acetylation (H3-Acetyl)
and methylation at Lys-4 (H3-K4M3), both chromatin modifica-
tions contributing to open up the gene locus for active
transcription [42]. Previous study has demonstrated significantly
increased H3-Acetyl and H3-K4M3 during Th17 differentiation,
indicating opening IL-17 gene locus for expression [29]. Indeed,
our results confirmed significant higher H3-Acetyl and H3-K4M3
in differentiated Th17 cells than that of the naı ¨ve T cells (Fig. 6A).
We next compared both modifications between WT and TCF-1
-/-
mice. Higher H3-Acetyl and H3-K4M3 were observed in TCF-
1
-/- thymocytes (Fig. 6B) and peripheral T cells (Fig. 6C). These
results suggest that lack of TCF-1 leads to opening up IL-17 locus
in thymus due to chromatin modifications. Such open state of IL-
17 locus is maintained in mature T cells due to preserved
chromatin modification patterns, which explains why peripheral
TCF-1
-/- T cells have high Th17 formation potential, although
TCF-1 cannot interferes with IL-17 production in mature T cells.
Altogether, our results demonstrate that TCF-1 mediates the
repression of IL-17 locus during T cell development by chromatin
modifications.
Discussion
Naı ¨ve T cells are pluripotent and able to differentiate into
various lineages of T helpers that produce distinct cytokines
mediating different immune responses. Critical cytokine loci, such
as IFNc (Th1), IL-4 (Th2) and IL-17 (Th17), are repressed in naı ¨ve
T cells until the engagement of antigens that initiate differentia-
tion. Previous studies have demonstrated the IFNc and IL-4 gene
loci undergo dramatic epigenetic changes in chromatin modifica-
tion, resulting in activation of their expression upon differentiation
to Th1 and Th2 respectively [43]. Similarly, during Th17
differentiation, the IL-17 locus also undergoes extensive chromatin
modification, leading to a significant increase in chromatin
accessibility for transcription activation [29]. Peripheral mature
T cells are thus capable of converting inactive cytokine gene loci to
active. Such a capability requires that the cytokine gene loci be
programmed into a reversible repressive state during T cell
development so that they can be de-repressed and further
activated once T cells migrate out of the thymus. However, little
is known about the mechanisms responsible for programming
cytokine gene loci during T cell development. In this study, we
demonstrated that TCF-1 is a critical factor required to repress IL-
17 gene locus in thymus. Compared to WT mice, mice lacking
TCF-1 had increased IL-17 gene expression both in thymic and
peripheral T cells, which was confirmed by a larger natural Th17
cell population in these mice (Fig. 1B-C). Furthermore, when
stimulated in vitro, even in the absence of TCFb and IL-6,
cytokines critical for Th17 formation, TCF-1
-/- T cells formed
Th17 cells, suggesting an elevated potential for Th17 formation in
the absence of TCF-1. Indeed, TCF-1
-/- T cells formed twice as
many Th17 cells than did WT cells in the presence of TGFb and
IL-6. Lastly, TCF-1
-/- mice and Rag1
-/- mice adoptively trans-
ferred with TCF-1
-/- T cells were more susceptible to induction of
Figure 5. TCF-1 does not affect IL-17 expression in mature T cells. (A) TCF-1, dnTCF-1, b-catenin, or active b-catenin expressed from MSCV
plasmids functioned normally in the regulation of a TCF-1 reporter. HEK293 cells were co-transfected with TOPflash reporter and MSCV-TCF-1, dnTCF,
b-catenin, or active b-catenin vectors, as indicated. Luciferase activity was measured 48 h after transfection and normalized to internal control Renilla
luciferase; n=2. (B) Expression of TCF-1 or dnTCF does not affect Th17 differentiation in either peripheral WT or TCF-1
-/- CD4 cells. Naı ¨ve WT or TCF-1
-/-
CD4 cells were infected with empty MSCV, MSCV-dnTCF-1 or MSCV-TCF-1, then differentiated under Th17 conditions. Production of IL-17A was
determined by intracellular staining. Percentage shown at the right upper corner was calculated as (IL-17+GFP+)/(GFP+)6100%. (C) Percentage of IL-
17
+GFP
+ cells as shown in (B); n=2 for each group. (D) Active b-catenin does not affect Th17 differentiation. Isolated naı ¨ve CD4 T cells from WT
control or b-cat
Tg mice were cultured under ThN or Th17 condition for three days. Representative flow cytometry plots of intracellular IL-17A staining
are shown. (E) Percentage of IL-17A-producing cells as shown in (D); n=2 for each group. Error bars indicate 6SEM. (F) Retrovirally expressed TCF-1
rescued defective TCF-1
-/- thymocyte development. CD4-CD8- thymocytes sorted from WT and TCF-1
-/- thymocytes were co-cultured with stroma cells
OP9-DL1. After 24 hrs, retrovirus expressing TCF-1 or Bcl-xL transduced cells, and allowed to differentiate for three more days. T cell development of
GFP+ and GFP- cells was then analyzed using CD4 and CD8 surface markers by flow cytometry.
doi:10.1371/journal.pone.0024768.g005
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our in vitro and in vivo experiments support that TCF-1 is
intrinsically required to suppress Th17 differentiation. Consistent
with our results, a recent study also demonstrated negative role of
TCF-1 in Th17 differentiation [44]. However, it was suggested
that TCF-1 likely regulate IL-17 at mature stage. In contrast, our
results support that TCF-1 modifies IL-17 gene locus during T cell
development in thymus, and such modifications are imprinted in
cells even after T cells mature and migrate out of thymus. Our
data do not exclude other alternative explanation. Since TCF
family has multiple members including TCF-3, TCF-4 as well as
LEF-1, we do not exclude the possibility that T cells at mature
stages use different members of TCF to regulate Th17, which
could explain why TCF-1 does not affect Th17 differentiation at
mature stage. However, dnTCF, which also interferes other TCF
function, did not affect Th17 differentiation in mature stage,
favoring that TCF-1 regulates IL-17 locus in immature stage. In
addition, we would like to mention that only mice were used in this
study. The mechanisms revealed in this study may not apply to
human T cells, as human T cells are not as stringent in terms of
lineage commitment in comparison to mouse T cells.
Although many transcription factors have been identified as
either positively or negatively regulating Th17 differentiation,
including RORct [17], Stat3 [45], Runx1[33], IRF4 [37], Ahr
[32], Batf [38], Foxp3 [46] and Ets-1 [29,34,35], TCF-1 is unique
because it regulates Th17 differentiation without affecting RORct
(Fig. 4A–B), whereas other transcription factors promote or inhibit
Th17 differentiation by regulating the levels of RORct. Further-
more, deletion of TCF-1 does not alter expression of the above
listed factors known to regulate Th17 differentiation (Fig. 4D). In
addition, TCF-1 does not affect Th17 differentiation in mature
peripheral T cells. We showed that overexpression of WT TCF-1,
Figure 6. The IL-17 locus in TCF-1
-/- thymocytes and peripheral T cells is in an open state. (A) IL-17 locus is opened up upon differentiation
to Th17 cells. H3-Acetyl and H3-K4M, both chromatin modifications indicating active gene locus, were measured in WT naı ¨ve T cells or differentiated
Th17 cells; (B-C) IL-17 locus is in open sate in TCF-1
-/- cells. H3-Acetyl and H3-K4M were compared between WT or TCF-1
-/- thymocytes (B) or peripheral
T cells. DNA was precipitated with anti-acetyl-histone H3 (H3-Acetyl) or trimethyl-histone H3 (H3-K4M3) antibodies. qRT- PCR-based ChIP analysis was
used to measure acetyl-histone H3 or trimethyl-histone within the IL-17 locus; n=4 for each group; error bars indicate 6SEM.
doi:10.1371/journal.pone.0024768.g006
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Th17 differentiation, which was not due to overexpression of
TCF-1, as restoration of TCF-1 expression in mature TCF-1
-/- T
cells also failed to interfere with Th17 differentiation (Fig. 5B–C).
In contrast, restoring expression of factors that affect Th17
differentiation in their corresponding knockout T cells usually
restores IL-17 production [17,35,45]. These results exclude the
possibility that TCF-1 regulates Th17 differentiation potential in
mature T cells, which raises the question of when and where TCF-
1 determines Th17 differentiation potential.
Many previous studies focused on how the cytokine environ-
ment determines the differentiation of mature T cells to specific
lineages of T helpers. However, T cell function is also shaped
during development in the thymus. The best example is the
positive and negative selection process in thymus to ensure the
specificity of T cell response to only foreign antigens [47]. Once T
cells are mature and migrate out of thymus, the specificity of T cell
response to antigens cannot be changed. Little is known about
whether and how T cell development in thymus affects the
potential of mature T cells to differentiate into a specific lineage of
T helpers. Our study supports the idea that TCF-1 determines the
Th17 differentiation potential during T cell development in the
thymus, but not in the periphery after maturation of T cells, and
thus indicates that the T cell development process can also shape
the potential of mature T helper cell differentiation, which is
critical for generating balanced immune responses and avoiding
autoimmunity.
T cell development is a complicated process that depends on
reprogramming chromatin structure to activate and repress a
network of genes critical for specification and function of T cells.
Acetylation and methylation are two critical epigenetic modifica-
tions of DNA for regulating gene expression by changing the
accessibility of the chromatin [42]. Chromatin remodeling of the
IL-17 locus has been detected during Th17 differentiation [29],
and in naı ¨ve T cells this locus is hypoacetylated (H3-Acetyl) and
hypomethylated at Lys-4 of histone 3 (H3-K4M3), indicating a
closed state. During Th17 differentiation, the IL-17 locus is slowly
transformed into an open state indicated by hyper-H3-Acetyl and
hyper-H3-K4M3. Our results demonstrate that the IL-17 locus in
TCF-1
-/- thymocytes is more acetylated (H3-Acetyl) and slightly
higher methylated (H3-K4M3) than in WT cells, suggesting an
abnormal open state of the IL-17 locus, which would explain the
increased levels of IL-17 mRNA and natural Th17 observed in
TCF-1
-/- thymocytes (Fig. 1). Thus, our results suggest there is a
TCF-1-mediated active process to repress the IL-17 locus by
epigenetic modifications during T cell development in thymus.
The presence of increased IL-17 mRNA levels and natural Th17
in both thymic and peripheral T cells of TCF-1
-/- mice further
suggests that TCF-1-mediated epigenetic modifications of IL-17
locus, once finished in the thymus, can be preserved even after T
cells migrate out of the thymus to the periphery. This explains our
observation that peripheral TCF-1
-/- T cells have high potential to
form Th17 (Fig. 2), although TCF-1 could not affect Th17
differentiation in mature T cells (Fig. 5). TCF-1-mediated
epigenetic modification of IL-17 locus is likely a key mechanism
for preventing T cells from generating overwhelming inflamma-
tory IL-17, which has been associated with numerous autoimmune
diseases [48]. This notion is supported by the fact that TCF-1
-/-
mice are extremely susceptible to EAE (Fig. 3).
Much remains unknown concerning detailed molecular mech-
anisms responsible for TCF-1-regulated IL-17 expression. b-
catenin has been reported to activate target gene expression
together with TCF-1 [26,49]. However, our results do not support
the idea that b-catenin as an activator of TCF-1 is involved in this
process, as a stabilized b-catenin transgene that is expressed in the
thymus did not affect IL-17 differentiation (Fig. 4). TCF-1 inhibits
target gene expression when it associates with the co-repressor
GRG in mouse (Groucho in Drosophila) [50]. However, it has not
yet been determined whether GRG is required for TCF-1 to
inhibit the IL-17 locus. It is possible that TCF-1 does not directly
inhibit IL-17 gene but via another factor. For example, TCF-1
may activate an IL-17 inhibitor or inhibit an IL-17 activator or
both. We have demonstrated that TCF-1 is a critical factor
required to inhibit IL-17 gene expression through epigenetic
modifications in the thymus, which is a critical mechanism for
generating appropriate Th17 responses. Disruption of this
mechanism likely leads to overt Th17 inflammation that
contributes to autoimmunity. TCF-1/b-catenin pathway plays a
role in multiple types of immune cells including dendritic cells. For
example, b-catenin has been shown to regulate Treg vs.
inflammatory T cell balance via dendritic cells [51]. Therefore,
TCF-1/b-catenin regulates multiple functions and multiple types
of cells in immune system. More studies on how different immune
cells integrate TCF-1/b-catenin signals to coordinate immune
responses are essential to understanding the function of this
important pathway in immune system.
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